Algorithme Pharma secures a partnership with Kilmer Capital Partners



    MONTREAL, Oct. 15 /CNW Telbec/ - Algorithme Pharma is very pleased to
announce that it has entered into a significant partnership with
Kilmer Capital Partners, a leading Canadian investment group. This association
will add to the business expertise and financial depth needed to ensure
Algorithme Pharma's plans to expand into new markets.
    Since first established in 1992, Algorithme Pharma has continuously
demonstrated its commitment to maintaining a high level of customer service
and unquestionable quality and reliability through the various phases of its
growth to date. Algorithme Pharma's ultimate goal is, and will remain,
providing its customers with the best contract research services.
    "Our investment group recognizes the expansion potential of Algorithme
Pharma, based on a solid track record of sound management and constant
development," says André La Forge, Managing Partner of Kilmer Capital
Partners.
    According to Louis Caillé, President and Chief Executive Officer of
Algorithme Pharma, "Management and staff are all very enthusiastic about the
growth and acquisition opportunities that this partnership will bring. Under
the terms of the agreement, there will be no changes in the Company's
management and personnel and the founders and current shareholders will retain
significant ownership of the Company. "

    About Algorithme Pharma

    Algorithme Pharma is one of the world's leading clinical research and
biopharmaceutical analysis companies, specializing in contractual research for
the international pharmaceutical industry. The Company conducts over
200 studies annually with the participation of some 7,000 volunteers. A
privately held Quebec company, Algorithme Pharma employs over
350 professionals. Algorithme Pharma has experienced tremendous growth -
nearly 400% - in the past five years. The Company is headquartered in Laval,
Quebec, and operates three other facilities, including its newest and largest,
the 68,000 square-foot Beaumont Clinic.

    About Kilmer Capital Partners

    Kilmer Capital is a private equity investment fund run by experienced
investors and business operators dedicated to building pre-eminent companies
in partnership with management. They provide patient equity capital to small
and mid-market companies seeking financing for expansion, acquisitions,
management buyouts, leveraged buyouts, restructurings, recapitalizations and
privatizations.

    www.algopharm.com
    www.kilmercapital.com




For further information:

For further information: Frédéric D. Tremblay, Public Relations Officer,
Etoile du Nord Public Relations, (514) 398-9758, ext. 243,
ftremblay@etoileworld.com; Maurice Boucher, Senior Consultant, Etoile du Nord
Public Relations, (514) 398-9758, ext. 253, mboucher@etoileworld.com; Source:
Louis Caillé, President and Chief Executive Officer, Algorithme Pharma

Organization Profile

ALGORITHME PHARMA

More on this organization

KILMER CAPITAL PARTNERS

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890